STN.TO vs. RMD
STN.TO (Stantec Inc.) and RMD (ResMed Inc.) are both stocks. STN.TO operates in Engineering & Construction (Industrials), while RMD operates in Medical Instruments & Supplies (Healthcare). Over the past 10 years, STN.TO returned 13.46%/yr vs 14.75%/yr for RMD. At a 0.19 correlation, their price movements are largely independent.
Performance
STN.TO vs. RMD - Performance Comparison
Loading charts...
Different Trading Currencies
STN.TO is traded in CAD, while RMD is traded in USD. To make them comparable, the RMD values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, STN.TO achieves a -20.63% return, which is significantly lower than RMD's -17.92% return. Over the past 10 years, STN.TO has underperformed RMD with an annualized return of 13.46%, while RMD has yielded a comparatively higher 14.75% annualized return.
STN.TO
- 1D
- -0.36%
- 1M
- -14.21%
- YTD
- -20.63%
- 6M
- -22.25%
- 1Y
- -29.01%
- 3Y*
- 8.82%
- 5Y*
- 14.98%
- 10Y*
- 13.46%
RMD
- 1D
- -1.21%
- 1M
- -4.36%
- YTD
- -17.92%
- 6M
- -21.73%
- 1Y
- -21.10%
- 3Y*
- -0.94%
- 5Y*
- 1.86%
- 10Y*
- 14.75%
STN.TO vs. RMD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
STN.TO Stantec Inc. | -20.63% | 15.61% | 6.81% | 65.43% | -7.62% | 74.09% | 14.27% | 24.95% | -13.44% | 5.18% |
RMD ResMed Inc. | -17.92% | 1.41% | 45.55% | -18.53% | -14.37% | 23.35% | 35.05% | 32.16% | 47.85% | 29.64% |
Correlation
The correlation between STN.TO and RMD is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Jul 7, 2006 | 0.19 |
Fundamentals
STN.TO:
CA$4.30
RMD:
$13.78
STN.TO:
23.88
RMD:
14.02
STN.TO:
1.00
RMD:
0.43
STN.TO:
1.48
RMD:
3.85
STN.TO:
CA$7.92B
RMD:
$5.54B
STN.TO:
CA$3.40B
RMD:
$3.42B
STN.TO:
CA$1.13B
RMD:
$2.10B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
STN.TO vs. RMD — Risk / Return Rank
STN.TO
RMD
STN.TO vs. RMD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Stantec Inc. (STN.TO) and ResMed Inc. (RMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| STN.TO | RMD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.19 | ||
| Sortino ratioReturn per unit of downside risk | -0.29 | ||
| Omega ratioGain probability vs. loss probability | 0.82 | 0.87 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | -0.79 | -0.56 | -0.23 |
| Martin ratioReturn relative to average drawdown | -1.77 | -1.29 | -0.48 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| STN.TO | RMD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.05 | -0.87 | -0.19 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.63 | 0.06 | +0.57 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.57 | 0.46 | +0.11 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.46 | 0.48 | -0.02 |
Drawdowns
STN.TO vs. RMD - Drawdown Comparison
The maximum STN.TO drawdown since its inception was -58.12%, which is greater than RMD's maximum drawdown of -50.37%. Use the drawdown chart below to compare losses from any high point for STN.TO and RMD.
Loading charts...
Drawdown Indicators
| STN.TO | RMD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.12% | -50.37% | -7.75% |
Max Drawdown (1Y)Largest decline over 1 year | -36.84% | -37.56% | +0.72% |
Max Drawdown (3Y)Largest decline over 3 years | -36.84% | -38.05% | +1.21% |
Max Drawdown (5Y)Largest decline over 5 years | -36.84% | -50.37% | +13.53% |
Max Drawdown (10Y)Largest decline over 10 years | -36.84% | -50.37% | +13.53% |
Current DrawdownCurrent decline from peak | -35.14% | -33.53% | -1.61% |
Average DrawdownAverage peak-to-trough decline | -13.03% | -13.21% | +0.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.42% | 16.44% | -0.02% |
Volatility
STN.TO vs. RMD - Volatility Comparison
Stantec Inc. (STN.TO) has a higher volatility of 13.38% compared to ResMed Inc. (RMD) at 10.74%. This indicates that STN.TO's price experiences larger fluctuations and is considered to be riskier than RMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| STN.TO | RMD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.38% | 10.74% | +2.64% |
Volatility (6M)Calculated over the trailing 6-month period | 23.66% | 19.96% | +3.70% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.65% | 24.52% | +3.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.76% | 31.68% | -7.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.86% | 32.17% | -8.31% |
Dividends
STN.TO vs. RMD - Dividend Comparison
STN.TO's dividend yield for the trailing twelve months is around 0.90%, less than RMD's 1.24% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RMD ResMed Inc. | 1.24% | 0.94% | 0.88% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% |
STN.TO Stantec Inc. | 0.90% | 0.69% | 0.74% | 0.73% | 1.11% | 0.93% | 1.50% | 1.58% | 1.84% | 1.42% | 1.33% | 1.22% |
Financials
STN.TO vs. RMD - Financials Comparison
This section allows you to compare key financial metrics between Stantec Inc. and ResMed Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
STN.TO vs. RMD - Profitability Comparison
STN.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Stantec Inc. reported a gross profit of 819.30M and revenue of 2.07B. Therefore, the gross margin over that period was 39.6%.
RMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported a gross profit of 890.98M and revenue of 1.43B. Therefore, the gross margin over that period was 62.3%.
STN.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Stantec Inc. reported an operating income of 174.60M and revenue of 2.07B, resulting in an operating margin of 8.4%.
RMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported an operating income of 499.81M and revenue of 1.43B, resulting in an operating margin of 34.9%.
STN.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Stantec Inc. reported a net income of 110.80M and revenue of 2.07B, resulting in a net margin of 5.4%.
RMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported a net income of 398.73M and revenue of 1.43B, resulting in a net margin of 27.9%.
Frequently Asked Questions
STN.TO and RMD have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for STN.TO and RMD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer